Tandem Diabetes Care | TNDM - Operating Expenses


Tandem Diabetes Care reported $268.35M in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Accuray USD 37.18M 567K Dec/2024
Align Technology USD 821.72M 43.15M Sep/2026
AtriCure USD 143.94M 3.22M Jun/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.13B 72M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Eli Lilly USD 10.52B 496M Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
ICU Medical USD 491.25M 8.59M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Roche Holding CHF 18.9B 2.12B Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026